Biostage, Inc. (BSTG)
Biostage has a market cap or net worth of $29.55 million. The enterprise value is $29.18 million.
Biostage has 9.44 million shares outstanding. The number of shares has increased by 9.25% in one year.
|Shares Change (YoY)||+9.25%|
|Shares Change (QoQ)||+0.50%|
|Owned by Insiders (%)||58.74%|
|Owned by Institutions (%)||0.19%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.18.
|Debt / Equity||0.18|
|Debt / EBITDA||-0.05|
|Debt / FCF||-0.04|
|Return on Equity (ROE)||-277.20%|
|Return on Assets (ROA)||-157.50%|
|Return on Capital (ROIC)||-492.60%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$490,000|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +124.26% in the last 52 weeks. The beta is -0.16, so Biostage's price volatility has been lower than the market average.
|52-Week Price Change||+124.26%|
|50-Day Moving Average||3.33|
|200-Day Moving Average||1.97|
|Average Volume (30 Days)||2,076|
Short Selling Information
|Short % of Shares Out||1.29%|
|Short % of Float||2.67%|
|Short Ratio (days to cover)||3.35|
|Earnings Per Share (EPS)||-$0.32|
The company has $501,000 in cash and $130,000 in debt, giving a net cash position of $371,000 or $0.04 per share.
|Cash & Cash Equivalents||501,000|
|Net Cash Per Share||$0.04|
|Book Value Per Share||0.08|
In the last 12 months, operating cash flow was -$3.05 million and capital expenditures -$7,000, giving a free cash flow of -$3.06 million.
|Operating Cash Flow||-3.05M|
|Free Cash Flow||-3.06M|
|FCF Per Share||-$0.32|
Dividends & Yields
Biostage does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on December 22, 2017. It was a reverse split with a ratio of 1:20.
|Last Split Date||Dec 22, 2017|